BSIM Therapeutics at the Lisbon Investor Conference

08 November, 2019

Large lic

BSIM Therapeutics pitched its drug discovery program focusing on transthyretin amyloidosis (ATTR) to several international investors present at the “Health Startup Day”, the second day of the Lisbon Investor Conference. The event was organized by Hovione Capital and took place on November 8, 2019, at Museu do Oriente.

By continuing to browse the site, you expressly agree that cookies will be stored on your computer to help measure statistics of visits and improve the quality of the contents offered.Learn more